Clinical Trial Update: 7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of 7-hydroxystaurosporine and topotecan hydrochloride in relapsed or progressed small cell lung cancer has completed, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• 7-hydroxystaurosporine (7-hydroxystaurosporine)
• Topotecan hydrochloride (topotecan hydrochloride)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-09-09